Imazalil (Enilconazole)
(Synonyms: 抑霉唑; Enilconazole) 目录号 : GC32111An imidazole fungicide
Cas No.:35554-44-0
Sample solution is provided at 25 µL, 10mM.
Imazalil is an imidazole fungicide that inhibits ergosterol biosynthesis.1 Imazalil inhibits the growth of various fungi in vitro including P. italicum, A. niger, U. maydis, B. alii, and C. cucumerinum in a pH-dependent manner (MICs = 0.005-2 μg/ml at pH 7).2 It inhibits S. cerevisiae, but not rat liver microsomal, cytochrome P450 enzymes (CYPs; IC50s = 0.088 and 80 μM, respectively), as well as aromatase CYP19 from human placental microsomes (IC50 = 0.34 μM).1,3 Imazalil activates the murine pregnane X receptor (PXR) in a concentration-dependent manner in a cell-based reporter assay.4 It increases hepatic CYP3A11 and CYP2B10 mRNA levels in mice when administered at a dose of 100 mg/kg. Imazalil also increases Ki-67-positive nuclei in liver sections and hepatic MCM2 mRNA levels, markers of cell proliferation, in mice when co-administered with the murine constitutive androstane receptor (mCAR) agonist TCPOBOP . Formulations containing imazalil have been used to control fungal infection in agriculture.
1.Vanden Bossche, H., Lauwers, W., Willemsens, G., et al.Molecular basis for the antimycotic and antibacterial activity of N-substituted imidazoles and triazoles: The inhibition of isoprenoid biosynthesisPestic. Sci.15(2)188-198(1984) 2.Siegel, M.R., Kerkenaar, A., and Kaars Sijpesteijn, A.Antifungal activity of the systemic fungicide imazalilNeth. J. Pl. Path.83(Suppl. 1)121-133(1977) 3.Vinggaard, A.M., Hnida, C., Breinholt, V., et al.Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitroToxicol. In Vitro14(3)227-234(2000) 4.Yoshimaru, S., Shizu, R., Tsuruta, S., et al.Acceleration of murine hepatocyte proliferation by imazalil through the activation of nuclear receptor PXRJ. Toxicol. Sci.43(7)443-450(2018)
Cas No. | 35554-44-0 | SDF | |
别名 | 抑霉唑; Enilconazole | ||
Canonical SMILES | C=CCOC(C1=CC=C(Cl)C=C1Cl)CN2C=CN=C2 | ||
分子式 | C14H14Cl2N2O | 分子量 | 297.18 |
溶解度 | DMSO : ≥ 100 mg/mL (336.50 mM);Water : 20 mg/mL (67.30 mM) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.365 mL | 16.8248 mL | 33.6496 mL |
5 mM | 0.673 mL | 3.365 mL | 6.7299 mL |
10 mM | 0.3365 mL | 1.6825 mL | 3.365 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet